You just read:

BioDelivery Sciences Announces Clonidine Topical Gel for Painful Diabetic Neuropathy Phase 2b Trial Fails to Meet its Primary Efficacy Endpoint

News provided by

BioDelivery Sciences International, Inc.

Dec 13, 2016, 06:55 ET